Ines Feki | Pharmacology | Excellence in Research

Mrs. Ines Feki | Pharmacology | Excellence in Research

Mrs. Ines Feki, Institut supérieur de Biotehnologie de Sfax et laboratoire de bioprocédés Environnementaux Centre of Biotechnology of Sfax (CBS), université de Sfax, Tunisia

Dr. Ines Feki is a distinguished academic and researcher specializing in pharmacology, toxicology, and pharmaceutics. She is currently an Assistant Professor at the Higher Institute of Biotechnology of Sfax, University of Sfax, Tunisia. Dr. Feki completed her PhD in Biological Sciences in 2006 and has been an active contributor to academic research and teaching for over two decades. Her work focuses on environmental bioprocesses and medical biotechnology, contributing to advancements in public health. As a prolific author, she has published 20 international journal articles and holds a patent. Dr. Feki is also a member of multiple professional committees, mentoring undergraduate and postgraduate students. She collaborates with renowned institutions worldwide, including universities in Japan and Tunisia. Her dedication to research and education exemplifies her commitment to advancing pharmacological sciences for societal benefit.

Professional Profile

Scopus

Assessment of Dr. Ines Feki for the “Research for Excellence in Research” Award

Dr. Ines Feki, currently affiliated with the Laboratory of Environmental Bioprocesses, Centre of Biotechnology of Sfax, demonstrates a solid academic and professional background with a focus on biological sciences and biotechnology. Her educational qualifications, including a PhD in Biological Sciences and a Master’s degree in Biological Engineering, reflect a foundation of advanced expertise. Furthermore, her professional journey, spanning over two decades, includes roles as an Assistant Professor at two prestigious universities in Tunisia, emphasizing her long-standing dedication to research and teaching.

Dr. Feki’s research contributions are notable, with 20 international journal publications across reputed platforms, a published patent, and several completed research projects. These achievements highlight her innovative approach and dedication to advancing pharmacology, toxicology, and pharmaceutics. Notably, her active role in editorial appointments and collaborative projects with international and national institutions underscores her ability to foster meaningful academic and research partnerships.

🎓 Education 

Dr. Ines Feki has a robust educational background in biological sciences and engineering. She earned her PhD in Biological Sciences from the Faculty of Sciences of Sfax, University of Sfax, in 2006, focusing on advanced biotechnological processes. Prior to that, she completed her Master’s degree in Biological Engineering from the Engineering School of Sfax in 1998, where she gained foundational expertise in innovative engineering applications in life sciences. Dr. Feki’s academic journey began with a Bachelor’s degree in Natural Sciences from the Faculty of Sciences of Sfax, completed in 1996. Her educational foundation has equipped her with interdisciplinary knowledge, merging biological sciences and engineering to address challenges in pharmacology and bioprocesses. This strong academic background has fueled her innovative contributions to medical biotechnology and environmental research.

💼 Professional Experience

Dr. Ines Feki has accumulated extensive academic and research experience over her career. From 2005 to 2011, she served as an Assistant Professor at the Faculty of Sciences of Gafsa, University of Gafsa, where she mentored students and conducted pivotal research. Since 2011, she has been an Assistant Professor at the Higher Institute of Biotechnology of Sfax (ISBS), University of Sfax, actively involved in teaching and research on pharmacology and biotechnology. She has contributed as a member of the Master’s Committee in Medical Biotechnology since 2022 and has been part of jury committees for Bachelor’s and Professional Master’s degrees since 2012. Dr. Feki has also collaborated on various research projects with esteemed international institutions, further cementing her reputation as a global academic leader. Her dedication to education and mentorship reflects her passion for fostering the next generation of scientists.

🏅 Awards and Recognition 

Dr. Ines Feki’s exemplary contributions to research and academia have earned her numerous accolades. She has published 20 international journal articles, with five as the lead author, showcasing her expertise and leadership in pharmacology and medical biotechnology. Her innovative work has been recognized with a published patent, highlighting her contributions to advancing biotechnology. As a valued member of academic committees, she has significantly influenced curriculum development and evaluation in higher education. Dr. Feki’s collaborations with prestigious institutions in Japan and Tunisia underline her global impact and recognition as a thought leader. Her role in guiding students and professionals has further established her as an influential educator and mentor in the field. These achievements underscore her commitment to fostering innovation and academic excellence.

🌍 Research Skills On Pharmacology

Dr. Ines Feki is a skilled researcher with expertise in pharmacology, toxicology, and pharmaceutics. Her work bridges the gap between environmental bioprocesses and medical biotechnology. She has completed three research projects, published 20 international journal articles, and holds a patent, showcasing her innovative capabilities. Dr. Feki collaborates with global institutions such as the University of Tsukuba in Japan and national laboratories in Tunisia, focusing on interdisciplinary approaches to address health challenges. Her editorial contributions to multiple publications highlight her strong analytical and communication skills. Additionally, Dr. Feki has guided numerous students in Bachelor’s and Master’s programs, ensuring the practical application of her research. Her expertise extends to designing, conducting, and publishing impactful studies, making her a leader in pharmacological sciences. Dr. Feki’s dedication to research is evident in her ability to develop innovative solutions and her commitment to knowledge dissemination.

📖 Publication Top Notes

  • Hepatoprotective Effect of Oleuropein-Rich Extract from Olive Leaves against Cadmium-Induced Toxicity in Mice
    • Authors: Jemai, H.; Mahmoudi, A.; Feryeni, A.; Chamkha, M.; Sayadi, S.
    • Citations: 19
    • Year: 2020
  • Comparative Study on Beneficial Effects of Hydroxytyrosol- and Oleuropein-Rich Olive Leaf Extracts on High-Fat Diet-Induced Lipid Metabolism Disturbance and Liver Injury in Rats
    • Authors: Fki, I.; Sayadi, S.; Mahmoudi, A.; Marrekchi, R.; Ghorbel, H.
    • Citations: 82
    • Year: 2020
  • Oleuropein and Hydroxytyrosol Protect Rats’ Pups against Bisphenol A Induced Hypothyroidism
    • Authors: Mahmoudi, A.; Ghorbel, H.; Feki, I.; Ayadi, L.; Sayadi, S.
    • Citations: 15
    • Year: 2018
  • Oleuropein and Hydroxytyrosol Rich Extracts from Olive Leaves Attenuate Liver Injury and Lipid Metabolism Disturbance in Bisphenol A-Treated Rats
    • Authors: Mahmoudi, A.; Hadrich, F.; Feki, I.; Fourati, H.; Sayadi, S.
    • Citations: 57
    • Year: 2018
  • Olive Phenolic Compounds Attenuate Deltamethrin-Induced Liver and Kidney Toxicity through Regulating Oxidative Stress, Inflammation, and Apoptosis
    • Authors: Maalej, A.; Mahmoudi, A.; Bouallagui, Z.; Marrekchi, R.; Sayadi, S.
    • Citations: 64
    • Year: 2017
  • Emerging Technologies for Recovery of Value-Added Components from Olive Leaves and Their Applications in Food/Feed Industries
    • Authors: Souilem, S.; Fki, I.; Kobayashi, I.; Sayadi, S.; Nakajima, M.
    • Citations: 67
    • Year: 2017
  • Evaluation of Hypocholesterolemic Effect of Oleuropein in Cholesterol-Fed Rats
    • Authors: Hadrich, F.; Mahmoudi, A.; Bouallagui, Z.; Feve, B.; Sayadi, S.
    • Citations: 50
    • Year: 2016
  • Comparative Study on Phenolic Profile and Antioxidant Potential of Six Tunisian Autochthonous Olive Cultivars
    • Authors: Gargouri, B.; Feki, I.; Mansour, A.M.; Bouaziz, M.
    • Citations: 0
    • Year: 2013
  • Hypoglycemic and Antioxidant Effects of Leaf Essential Oil of Pelargonium graveolens L’Hér. in Alloxan-Induced Diabetic Rats
    • Authors: Boukhris, M.; Bouaziz, M.; Feki, I.; El Feki, A.; Sayadi, S.
    • Citations: 127
    • Year: 2012
  • Biochemical and Histological Liver Changes Occurred after Iron Supplementation and Possible Remediation by Garlic Consumption
    • Authors: Ghorbel, H.; Feki, I.; Friha, I.; Boudawara, M.; Sayadi, S.
    • Citations: 3
    • Year: 2011

Dimple Modi | Toxicology | Best Researcher Award

Dimple Modi | Toxicology | Best Researcher Award

Investigator/Principal Scientist at GlaxoSmithKline, United States 🎓

Dimple Modi is an accomplished scientific leader with over 12 years of experience in pharmaceutical research and formulation development. Specializing in dermatology/topical and parenteral applications, Modi has a proven track record in leading cross-functional teams, optimizing drug formulations, and advancing projects from conceptualization to late-stage development. With expertise in regulatory compliance, project management, and innovative drug delivery systems, Modi is known for fostering innovation and driving successful drug development initiatives.

Professional Profile 

🎓Education🧑‍🎓

Dimple Modi earned a PhD in Pharmaceutical Science from Saint Joseph’s University (formerly University of the Sciences) in Philadelphia, PA, where their research focused on enhancing the oil solubility of BCS Class II drugs and increasing drug loading in nanoemulsions. Modi also holds a Master of Science in Pharmaceutical Manufacturing Practices from Stevens Institute of Technology in Hoboken, NJ, and a Bachelor of Science in Pharmacy from L.M. College of Pharmacy in Ahmedabad, Gujarat, India.

💼Work Experience

Dimple Modi, in their role as Investigator, Drug Product Development at GlaxoSmithKline, has excelled in leading the development and optimization of long-acting injectable suspensions and parenteral solutions. Modi oversees clinical formulation strategies and project management from early to late phases, while pioneering innovative extemporaneous compounding methods. Previously, as a Senior Research Scientist at GlaxoSmithKline, Modi conducted pivotal pre-formulation studies and developed platform cream formulations using DOE methodologies. At Lupin Pharmaceuticals, Modi advanced dermatological semisolid dosage forms, managed technology transfers, and authored critical regulatory documentation. Their analytical expertise and adherence to cGMP and cGLP guidelines were honed during their tenure as an Analytical Scientist.

🔍Research Focus 

Dimple Modi’s research focuses on the development and optimization of drug formulations, particularly in dermatology and parenteral applications. Key areas include enhancing drug solubility, optimizing delivery systems, and advancing formulation strategies from lab-scale to pilot-scale manufacturing. Modi is known for innovative approaches in drug development and regulatory compliance.

🏆Awards and Honors

  • Exceptional Science Award (2018): Recognized for designing and developing a platform cream formulation that accelerated development timelines for dermatology products.
  • Multiple Bronze/Silver Awards: Received within GlaxoSmithKline for scientific accomplishments.
  • Successfully Achieved 14 ANDA Submissions and Approvals: Demonstrates significant contributions to regulatory achievements.
  • Leadership in Career Development: Actively involved in initiatives to enhance diversity and mentorship within the industry.

Conclusion

Dimple Modi’s impressive track record in pharmaceutical research, combined with leadership skills and recognized innovations, makes them a strong candidate for the “Best Researcher Award.” Their ability to drive forward complex projects, mentor future scientists, and contribute to significant advancements in drug development aligns well with the criteria for such an award. Enhancing visibility through publications and broader impact initiatives could further solidify their suitability for the award.

📖Publications : 

  1. Long acting injectables for the treatment of prostate cancer
    Modi, D., Hussain, M.S., Ainampudi, S., Prajapati, B.G.
    Journal of Drug Delivery Science and Technology, 2024, 100, 105996
  2. In situ evaluation of the impact of metformin or verapamil coadministration with vildagliptin on its regional absorption from the rabbit’s intestine
    Elmeniar, A.M., Osman, M.A., El-Gizawy, S.A., Haggag, Y.A., Tambuwala, M.M.
    Biopharmaceutics and Drug Disposition, 2024, 45(2), pp. 71–82
  3. Enhancing Oil Solubility of BCS Class II Drug Phenytoin Through Hydrophobic Ion Pairing to Enable High Drug Load in Injectable Nanoemulsion to Prevent Precipitation at Physiological pH With a Potential to Prevent Phlebitis
    Modi, D., Jonnalagadda, S., Campbell, G.A., Dalwadi, G.
    Journal of Pharmaceutical Sciences, 2023, 112(9), pp. 2427–2443
  4. Accelerate development of topical cream drug product using a common platform base formulation
    Modi, D., Sharma, H., Campbell, G.
    Pharmaceutical Development and Technology, 2020, 25(6), pp. 767–778
  5. Understanding the role of sodium lauryl sulfate on the biorelevant solubility of a combination of poorly water-soluble drugs using high throughput experimentation and mechanistic absorption modeling
    Bahr, M.N., Modi, D., Patel, S., Campbell, G., Stockdale, G.
    Journal of Pharmacy and Pharmaceutical Sciences, 2019, 22(1), pp. 221–246